Comparison of epidermal growth factor and heparin-binding epidermal growth factor-like growth factor for prevention of experimental necrotizing enterocolitis

Journal of Pediatric Gastroenterology and Nutrition

Volumn 47, Issue 1, 2008, Pages 11-18

  Dvorak, Bohuslav ^a   Khailova, Ludmila ^a   Clark, Jessica A ^b   Hosseini, Dania Molla ^a   Arganbright, Kelly M ^a   Reynolds, Charity A ^a   Halpern, Melissa D ^a  

^a UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

^b WASHINGTON UNIVERSITY   (United States)

Author keywords

Epidermal growth factor; Heparin binding epidermal growth factor like growth factor; Intestinal injury; Rat

Indexed keywords

EPIDERMAL GROWTH FACTOR; EPIDERMAL GROWTH FACTOR RECEPTOR; HEPARIN BINDING EPIDERMAL GROWTH FACTOR; HEPARIN-BINDING EGF-LIKE GROWTH FACTOR; SIGNAL PEPTIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASPHYXIA; CELL DENSITY; CELL SURVIVAL; COLD STRESS; COMPARATIVE STUDY; CONTROLLED STUDY; DIET; DRUG EFFECT; DRUG EFFICACY; EXPERIMENTAL ANIMAL; EXPERIMENTAL MODEL; EXPERIMENTAL STUDY; GENE EXPRESSION; GOBLET CELL; ILEUM; INTESTINE INJURY; NECROTIZING ENTEROCOLITIS; NEWBORN; NONHUMAN; NUCLEOTIDE SEQUENCE; PREMATURITY; PRIORITY JOURNAL; PROTECTION; PROTEIN EXPRESSION; RAT; ANIMAL; APOPTOSIS; DOSE RESPONSE; DRUG POTENTIATION; METABOLISM; ORAL DRUG ADMINISTRATION; PATHOLOGY; RANDOMIZATION; SPRAGUE DAWLEY RAT; TREATMENT OUTCOME;

RATTUS;

ADMINISTRATION, ORAL; ANIMALS; ANIMALS, NEWBORN; APOPTOSIS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG SYNERGISM; ENTEROCOLITIS, NECROTIZING; EPIDERMAL GROWTH FACTOR; ILEUM; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; RANDOM ALLOCATION; RATS; RATS, SPRAGUE-DAWLEY; TREATMENT OUTCOME;

EID: 55549144378     PISSN: 02772116     EISSN: None     Source Type: Journal    
DOI: 10.1097/MPG.0b013e3181788618     Document Type: Article

References (41)

1. Caplan MS, MacKendrickW. Necrotizing enterocolitis: a review of pathogenetic mechanisms and implications for prevention. Pediatr Pathol 1993;13:357-69.
2. Hsueh W, Caplan MS, Qu XW, et al. Neonatal necrotizing enterocolitis: clinical considerations and pathogenetic concepts. Pediatr Dev Pathol 2003;6:6-23.
3. Duh G, Mouri N, Warburton D, et al. EGF regulates early embryonic mouse gut development in chemically defined organ culture. Pediatr Res 2000;48:794-802.
4. Dvorak B, Fituch CC, Williams CS, et al. Increased epidermal growth factor levels in human milk of mothers with extremely premature infants. Pediatr Res 2003;54:15-9.
5. Shin CE, Falcone RA Jr, Stuart L, et al. Diminished epidermal growth factor levels in infants with necrotizing enterocolitis. J Pediatr Surg 2000;35:173-6.
6. Dvorak B, Halpern MD, Holubec H, et al. Epidermal growth factor reduces the development of necrotizing enterocolitis in a neonatal rat model. Am J Physiol Gastrointest Liver Physiol 2002;282:G156-64.
7. Halpern MD, Dominguez JA, Dvorakova K, et al. Ileal cytokine dysregulation in experimental necrotizing enterocolitis is reduced by epidermal growth factor. J Pediatr Gastroenterol Nutr 2003; 36:126-33.
8. Halpern MD, Holubec H, Clark JA, et al. Epidermal growth factor reduces hepatic sequelae in experimental necrotizing enterocolitis. Biol Neonate 2006;89:227-35.
9. Halpern MD, Holubec H, Saunders TA, et al. Bile acids induce ileal damage during experimental necrotizing enterocolitis. Gastroenterology 2006;130:359-72.
10. Clark JA, Lane RH, Maclennan NK, et al. Epidermal growth factor reduces intestinal apoptosis in an experimental model of necrotizing enterocolitis. Am J Physiol Gastrointest Liver Physiol 2005; 288:G755-62.
11. Clark JA, Doelle SM, Halpern MD, et al. Intestinal barrier failure during experimental necrotizing enterocolitis: protective effect of EGF treatment. Am J Physiol Gastrointest Liver Physiol 2006; 291:G938-49.
12. Michalsky MP, Lara-Marquez M, Chun L, et al. Heparin-binding EGF-like growth factor is present in human amniotic fluid and breast milk. J Pediatr Surg 2002;37:1-6.
13. Dvorak B, Clark JA, Doelle SM, et al. HB-EGF decreases the incidence of necrotizing enterocolitis in a rat model. Pediatr Res 2004;55:464A-5A.
14. Feng J, El-Assal ON, Besner GE. Heparin-binding epidermal growth factor-like growth factor decreases the incidence of necrotizing enterocolitis in neonatal rats. J Pediatr Surg 2006; 41:144-9.
15. Holbro T, Civenni G, Hynes NE. The ErbB receptors and their role in cancer progression. Exp Cell Res 2003;284:99-110.
16. Junttila TT, Sundvall M, Maatta JA, et al. Erbb4 and its isoforms: selective regulation of growth factor responses by naturally occurring receptor variants. Trends Cardiovasc Med 2000; 10:304-10.
17. Gibson UE, Heid CA, Williams PM. A novel method for real time quantitative RT-PCR. Genome Res 1996;6:995-1001.
18. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of proteindye binding. Anal Biochem 1976;72:248-54.
19. Guthrie SO, Gordon PV, Thomas V, et al. Necrotizing enterocolitis among neonates in the United States. J Perinatol 2003; 23:278-85.
20. Lemons JA, Bauer CR, OhW, et al. Very low birth weight outcomes of the National Institute of Child Health and Human Development Neonatal Research Network, January 1995 through December 1996. Pediatrics 2001;107:E1.
21. Lonnerdal B. Breast milk: a truly functional food. Nutrition 2000; 16:509-11.
22. Lucas A, Cole TJ. Breast milk and neonatal necrotising enterocolitis. Lancet 1990;336:1519-23.
23. Dvorak B. Epidermal growth factor and necrotizing enterocolitis. Clin Perinatol 2004;31:183-92.
24. Warner BW, Warner BB. Role of epidermal growth factor in the pathogenesis of neonatal necrotizing enterocolitis. Semin Pediatr Surg 2005;14:175-80.
25. Moran JR, Courtney ME, Orth DN, et al. Epidermal growth factor in human milk: daily production and diurnal variation during early lactation in mothers delivering at term and at premature gestation. J Pediatr 1983;103:402-5.
26. Feng J, Besner GE. Heparin-binding epidermal growth factor-like growth factor promotes enterocyte migration and proliferation in neonatal rats with necrotizing enterocolitis. J Pediatr Surg 2007; 42:214-20.
27. Aviezer D, Yayon A. Heparin-dependent binding and autophosphorylation of epidermal growth factor (EGF) receptor by heparinbinding EGF-like growth factor but not by EGF. Proc Natl Acad Sci U S A 1994;91:12173-7.
28. Higashiyama S, Abraham JA, Klagsbrun M. Heparin-binding EGFlike growth factor stimulation of smooth muscle cell migration: dependence on interactions with cell surface heparan sulfate. J Cell Biol 1993;122:933-40.
29. Shishido Y, Sharma KD, Higashiyama S, et al. Heparin-like molecules on the cell surface potentiate binding of diphtheria toxin to the diphtheria toxin receptor/membrane-anchored heparin-binding epidermal growth factor-like growth factor. J Biol Chem 1995; 270:29578-85.
30. Takazaki R, Shishido Y, Iwamoto R, et al. Suppression of the biological activities of the epidermal growth factor (EGF)-like domain by the heparin-binding domain of heparin-binding EGFlike growth factor. J Biol Chem 2004;279:47335-43.
31. Anand RJ, Leaphart CL, Mollen KP, et al. The role of the intestinal barrier in the pathogenesis of necrotizing enterocolitis. Shock 2007;27:124-33.
32. Hackam DJ, Upperman JS, Grishin A, et al. Disordered enterocyte signaling and intestinal barrier dysfunction in the pathogenesis of necrotizing enterocolitis. Semin Pediatr Surg 2005; 14:49-57.
33. Israel EJ. Neonatal necrotizing enterocolitis: a disease of the immature intestinal mucosal barrier. Acta Paediatr Suppl 1994;396:27- 32.
34. Walker WA. Role of the mucosal barrier in toxin/microbial attachment to the gastrointestinal tract. Ciba Found Symp 1985;112:34- 56.
35. Xia G, Martin AE, Michalsky MP, et al. Heparin-binding EGF-like growth factor preserves crypt cell proliferation and decreases bacterial translocation after intestinal ischemia/reperfusion injury. J Pediatr Surg 2002;37:1081-7.
36. El-Assal ON, Besner GE. HB-EGF enhances restitution after intestinal ischemia/reperfusion via PI3K/Akt and MEK/ERK1/2 activation. Gastroenterology 2005;129:609-25.
37. Bernal NP, Stehr W, Coyle R, et al. Epidermal growth factor receptor signaling regulates Bax and Bcl-w expression and apoptotic responses during intestinal adaptation in mice. Gastroenterology 2006;130:412-23.
38. Michalsky MP, Kuhn A, Mehta V, et al. Heparin-binding EGF-like growth factor decreases apoptosis in intestinal epithelial cells in vitro. J Pediatr Surg 2001;36:1130-5.
39. Jilling T, Lu J, Jackson M, et al. Intestinal epithelial apoptosis initiates gross bowel necrosis in an experimental model of neonatal necrotizing enterocolitis. Pediatr Res 2004;55:622-9.
40. Knott AW, Juno RJ, Jarboe MD, et al. EGF receptor signaling affects bcl-2 family gene expression and apoptosis after massive small bowel resection. J Pediatr Surg 2003;38:875-80.
41. Halpern MD, Clark JA, Saunders TA, et al. Reduction of experimental necrotizing enterocolitis with anti-TNF-alpha. Am J Physiol Gastrointest Liver Physiol 2006;290:G757-64.